Limits...
Anemia associated with chronic heart failure: current concepts.

Shah R, Agarwal AK - Clin Interv Aging (2013)

Bottom Line: Anemia is a frequent comorbidity of heart failure and is associated with poor outcomes.Anemia in heart failure is considered to develop due to a complex interaction of iron deficiency, kidney disease, and cytokine production, although micronutrient insufficiency and blood loss may contribute.Treatment with erythropoietin-stimulating agents has been considered alone or in combination with iron, but robust evidence to dictate clear guidelines is not currently available.

View Article: PubMed Central - PubMed

Affiliation: Division of Nephrology, The Ohio State University, Columbus, Ohio 43210, USA. anil.agarwal@osumc.edu

ABSTRACT
Anemia is a frequent comorbidity of heart failure and is associated with poor outcomes. Anemia in heart failure is considered to develop due to a complex interaction of iron deficiency, kidney disease, and cytokine production, although micronutrient insufficiency and blood loss may contribute. Currently, treatment of anemia of heart failure lacks clear targets and specific therapy is not defined. Intravenous iron use has been shown to benefit anemic as well as nonanemic patients with heart failure. Treatment with erythropoietin-stimulating agents has been considered alone or in combination with iron, but robust evidence to dictate clear guidelines is not currently available. Available and emerging new agents in the treatment of anemia of heart failure will need to be tested in randomized, controlled studies.

Show MeSH

Related in: MedlinePlus

Point your SmartPhone at the code above. If you have a QR code reader the video abstract will appear. Or use: http://dvpr.es/UjtKUa
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3569049&req=5

f2-cia-8-111: Point your SmartPhone at the code above. If you have a QR code reader the video abstract will appear. Or use: http://dvpr.es/UjtKUa


Anemia associated with chronic heart failure: current concepts.

Shah R, Agarwal AK - Clin Interv Aging (2013)

Point your SmartPhone at the code above. If you have a QR code reader the video abstract will appear. Or use: http://dvpr.es/UjtKUa
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3569049&req=5

f2-cia-8-111: Point your SmartPhone at the code above. If you have a QR code reader the video abstract will appear. Or use: http://dvpr.es/UjtKUa
Bottom Line: Anemia is a frequent comorbidity of heart failure and is associated with poor outcomes.Anemia in heart failure is considered to develop due to a complex interaction of iron deficiency, kidney disease, and cytokine production, although micronutrient insufficiency and blood loss may contribute.Treatment with erythropoietin-stimulating agents has been considered alone or in combination with iron, but robust evidence to dictate clear guidelines is not currently available.

View Article: PubMed Central - PubMed

Affiliation: Division of Nephrology, The Ohio State University, Columbus, Ohio 43210, USA. anil.agarwal@osumc.edu

ABSTRACT
Anemia is a frequent comorbidity of heart failure and is associated with poor outcomes. Anemia in heart failure is considered to develop due to a complex interaction of iron deficiency, kidney disease, and cytokine production, although micronutrient insufficiency and blood loss may contribute. Currently, treatment of anemia of heart failure lacks clear targets and specific therapy is not defined. Intravenous iron use has been shown to benefit anemic as well as nonanemic patients with heart failure. Treatment with erythropoietin-stimulating agents has been considered alone or in combination with iron, but robust evidence to dictate clear guidelines is not currently available. Available and emerging new agents in the treatment of anemia of heart failure will need to be tested in randomized, controlled studies.

Show MeSH
Related in: MedlinePlus